Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products.

from Reuters: Health News https://reut.rs/2AFPHud
via IFTTT
from Reuters: Health News https://reut.rs/2AFPHud
via IFTTT
Post a Comment